Featured
FDA Approves First Gene Therapy to Restore Natural Hearing in OTOF-Related Deafness
The FDA has granted accelerated approval to Otarmeni (formerly DB-OTO), the first and only in vivo gene therapy for severe-to-profound sensorineural h...
Read Full Story →